{"id":"W2807081886","doi":"10.1200/jco.2018.36.18_suppl.lba4001","title":"Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Hazard ratio; Clinical endpoint; FOLFIRINOX; Pancreatic cancer; Gastroenterology; Irinotecan; Surgery; Cancer; Randomized controlled trial; Confidence interval; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002423719,0.001907005,0.001992196,0.0004921171,0.0004011094,0.0009270316,0.0009482824,0.001579083,0.004858196],"category_scores_gemma":[0.001542621,0.0005262924,0.001474766,0.0004926532,0.0008745439,0.0006954458,0.0004614222,0.003018297,0.0009317407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001112895,"about_ca_system_score_gemma":0.001332264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001271905,"about_ca_topic_score_gemma":0.003026556,"domain_scores_codex":[0.9993529,0.0004399308,0.00001895309,0.00007671442,0.00003482564,0.00007671603],"domain_scores_gemma":[0.9992384,0.0001351753,0.0002217799,0.00005556392,0.00004042107,0.0003087304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9638329,0.007110884,0.001546472,0.0006500643,0.0006126371,0.00007799217,0.0000560617,0.0006063927,0.004047352,0.0001560445,0.002881308,0.01842179],"study_design_scores_gemma":[0.946523,0.04836261,0.002132542,0.00004588054,0.0003890192,0.00009602994,0.00001530636,0.0004945081,0.000453316,0.0001054718,0.001371958,0.00001031521],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9754677,0.007755608,0.0007113045,0.002123751,0.00055167,0.006030444,0.002745111,0.0002258654,0.004388487],"genre_scores_gemma":[0.970508,0.003591818,0.003241017,0.00254258,0.000657304,0.008645696,0.00482018,0.00006513133,0.005928405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004858196,"threshold_uncertainty_score":0.01625228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1264772848552606,"score_gpt":0.4860946307585331,"score_spread":0.3596173459032724,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}